Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
2.850
+0.040 (1.42%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Cardiff Oncology Employees
As of December 31, 2024, Cardiff Oncology had 33 total employees, including 32 full-time and 1 part-time employees. The number of employees increased by 1 or 3.13% compared to the previous year.
Employees
33
Change (1Y)
1
Growth (1Y)
3.13%
Revenue / Employee
$20,697
Profits / Employee
-$1,377,424
Market Cap
189.59M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
CRDF News
- 3 days ago - Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 days ago - Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer - GlobeNewsWire
- 7 weeks ago - Cardiff Oncology, Inc. (CRDF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update - GlobeNewsWire
- 7 weeks ago - Cardiff Oncology to Present at Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Cardiff Oncology to Report Fourth Quarter 2024 Results and Provide Business Update - GlobeNewsWire
- 2 months ago - Cardiff Oncology: Pioneering RAS-Mutated Cancer Therapies With Onvansertib - Seeking Alpha
- 4 months ago - Undercovered Dozen: Ubiquiti, Ready Capital, Cardiff Oncology, Vodafone + - Seeking Alpha